Results 31 to 40 of about 3,036,447 (259)
Microbiota and hepatic diseases
Лечащий Врач, 2021 The data on the existing knowledge in the field of intestinal microbiota influence on human diseases were presented, in particular, non-alcoholic fat liver disease, alcoholic liver disease, inflammatory intestinal diseases and infectious gastrointestinal
T. E. Polunina
doaj
Advances in the concomitant chronic liver disease and colorectal cancer liver metastasis [PDF]
Waike lilun yu shijianLiver metastasis is a key factor contributing to the poor prognosis of patients with colorectal cancer (CRC), and chronic liver diseases promote the occurrence and development of CRC liver metastasis (CRLM) through various mechanisms such as altering the
YANG Yue, ZHAO Lei
doaj +1 more source
, 2020 Introduction. Today, the most common pathologies among the chronic diffuse liver diseases is non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. The aim of the study. The aim of the work was to study the peculiarities of the the state
N. Matkovska
core +1 more source
A study of thyroid hormones in alcoholic liver diseases [PDF]
, 2021 Background and objectives Alcohol is a common cause of cirrhosis all over the world including India and alcoholic liver disease is among theten most common causes of death worldwide. Alcoholic liver diseases affect most of the organs in our body.
Vijaitha S M
core +1 more source
World Journal of Surgical Oncology, 2010 Background The incidence of hepatocellular cancer in complicated alcoholic and non-alcoholic fatty liver diseases is on the rise in western countries as well in our country. Vascular adhesion protein-1 (VAP-1) levels have been presented as new marker. In
Kemik Ozgur +6 more
doaj +1 more source
Design and analysis strategies for robust microbiome ageing research
FEBS Letters, EarlyView.The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
Non-alcoholic fatty liver disease: a global concern
, 2022 Liver disease is a worldwide issue with death rates exponentially increasing over the last 50 years. Although there are many underlying aetiologies, one of the top three causes of liver disease is non-alcoholic fatty liver disease (NAFLD), which is an ...
Mortimore, G.
core +1 more source
The SGOT/SGPT ratio in alcoholic liver disease.
Acta Médica Portuguesa, 1981 The SGOT/SGPT ratio has been estimated in 207 patients with alcoholic liver disease and in 3 control groups (43 viral hepatitis, 30 non-alcoholic chronic liver disease and 42 obstructive jaundice).
Patrícia S. Alves +2 more
doaj +1 more source
Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases
Frontiers in Cellular and Infection Microbiology, 2022 The liver is directly connected to the intestines through the portal vein, which enables the gut microbiota and gut-derived products to influence liver health.
Jing Liu +6 more
doaj +1 more source
Structure‐forward targeting of claudins with synthetic binders
FEBS Letters, EarlyView.Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source